tradingkey.logo
搜索

Co-Diagnostics Inc

CODX
添加自选
1.630USD
+0.030+1.88%
收盘 05/14, 16:00美东报价延迟15分钟
113.83K总市值
亏损市盈率 TTM

Co-Diagnostics Inc

1.630
+0.030+1.88%
查看详细走势图
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.88%

5天

-15.54%

1月

+18.12%

6月

+392.00%

今年开始到现在

+866.79%

1年

+373.15%

TradingKey Co-Diagnostics Inc股票评分

单位: USD 更新时间: 2026-05-13

操作建议

Co-Diagnostics Inc当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名128/206位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价30.00。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Co-Diagnostics Inc评分

相关信息

行业排名
128 / 206
全市场排名
296 / 4487
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Co-Diagnostics Inc亮点

亮点风险
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
业绩增长期
公司处于发展阶段,最新年度总收入622.49K美元
利润高增长
公司净利润处于行业前列,最新年度总收入622.49K美元
估值高估
公司最新PE估值-0.00,处于3年历史高位
机构减仓
最新机构持股248.15K股,环比减少39.01%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值24.34K
活跃度降低
近期活跃度降低,过去20天平均换手率-0.81

分析师目标

根据 2 位分析师
持有
评级
30.000
目标均价
+1171.19%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Co-Diagnostics Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Co-Diagnostics Inc简介

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
公司代码CODX
公司Co-Diagnostics Inc
CEOEgan (Dwight H)
网址https://codiagnostics.com/
KeyAI